Health Industry Updates: Psychedelic Drug Stocks Rise Amid FDA Acceleration Order
Published on: April 21, 2026, 6:32 p.m. | Source: Devdiscourse
Shares of psychedelic drug companies surged following an executive order by President Trump directing expedited FDA reviews of such treatments. AtaiBeckley, Compass Pathways, Enveric BioSciences, GH Research, and other firms saw significant stock gains. The order also called for increased federal funding for psychedelic research.
